Idera Pharmaceuticals, Inc. (IDRA:NASDAQ) Investor Relations Material

Overview

Idera Pharmaceuticals is a biotech company that pioneers innovative drugs derived from DNA and RNA to treat a variety of medical conditions such as infectious diseases, autoimmune and inflammatory disorders, cancer, and asthma or allergies. Their portfolio also includes vaccine adjuvants.

Annual Reports

Frequently Asked Questions

What is Idera Pharmaceuticals, Inc.'s ticker?

Idera Pharmaceuticals, Inc.'s ticker is IDRA

What exchange is Idera Pharmaceuticals, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Idera Pharmaceuticals, Inc.'s headquarters?

They are based in Exton, Pennsylvania

How many employees does Idera Pharmaceuticals, Inc. have?

There are 51-200 employees working at Idera Pharmaceuticals, Inc.

What is Idera Pharmaceuticals, Inc.'s website?

It is http://www.iderapharma.com

What type of sector is Idera Pharmaceuticals, Inc.?

Idera Pharmaceuticals, Inc. is in the Healthcare sector

What type of industry is Idera Pharmaceuticals, Inc.?

Idera Pharmaceuticals, Inc. is in the Biotechnology industry

Who are Idera Pharmaceuticals, Inc.'s peers and competitors?

The following five companies are Idera Pharmaceuticals, Inc.'s industry peers:

- Ovid Therapeutics Inc.

- Optiva

- Protalix BioTherapeutics, Inc.

- Bellicum Pharmaceuticals Inc

- Sangamo Therapeutics